Evaluation of Cerebral Vasoreactivity in Type2 Diabetic Patients by using Transcranial Doppler Ultrasonography (TCD)
Keywords:
Diabetes mellitus, Cerebral vasoreactivity, Transcranial Doppler Ultrasonography.Abstract
Background Type 2 diabetes mellitus (T2DM) is associated with an increased risk of cardiovascular and cerebrovascular diseases with high mortality and disability. Cerebral vasomotor reactivity (VMR), one of the most accurate markers of cerebral hemodynamics, has been shown to be impaired in subjects with carotid artery steno-occlusive disease and associated with an increased risk of ischemic events. Transcranial Doppler ultrasonography )TCD( study have been used to investigate cerebral vasoreactivity to identify patients with increased risk and to better plan the treatment. Objective: The aim of study was to assess cerebral vasoreactivity among type2 diabetes mellitus patients by using transcranial Doppler ultrasonography. Patients and method: sixty five persons (45 type 2 diabetic patients and 20 normal control) (32 male,33 female) with mean age (46.95 ±7.459) enrolled in this study. The study groups are collected randomly from Al Najaf center for Diabetic and endocrine in Al Sader teaching hospital during the time between January 2016 to June 2016. TCD examination was performed in Middle Euphrates Neuroscience Center for all stuied group to assess cerebral vasoreactivity in middle cerebral artery by breath holing test,hyperventilation test (HV), Transient hyperemic test (THRR). (Statistical Package of Social Sciences) SPSS version 23 was used for the statistical analysis. Results : There was highly significant change of breath holding index BHI{ between control group and diabetic group} (p.value<0.05) and significant change of HV between control group and diabetic group . Also statistical significant change in THRR in relation to glycemic control(p.value< 0.05). Conclusion : There was significant changes in TCD indices that assessed cerebral vasoreactivity in breath holding index, ,hyperventilation in type2 diabetic patients compared with control subjects.References
WHO, Diabetes Fact sheet No. 312. WHO: October 2013. Retrieved March 25, 2014.
Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes care. 2009 Jul 1;32(7):1335-43.
Shoback, edited by David G. Gardner, Dolores "Chapter 17".Greenspan's basic & clinical endocrinology (9th ed.). New York: McGraw-Hill Medical. (2011). ISBN 0-07-162243-8.
Schwertfeger N, Neu P, Schlattmann P, Lemke H, Heuser I, Bajbouj M. Cerebrovascular reactivity over time course in healthy subjects. Journal of the Neurological Sciences. 2006;249(2):135–139.
Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L: Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 63: 1181–1186, 2004.
Trauernicht AK, Sun H, Patel KP, Mayhan WG. Enalapril Prevents Impaired Nitric Oxide Synthase–Dependent Dilatation of Cerebral Arterioles in Diabetic Rats. Stroke. 2003 Nov 1;34(11):2698-703.
Makimattila S, Malmberg-Ceder K, Hakkinen AM, Vuori K, Salonen O, Summanen P, Yki-Jarvinen H, Kaste M, Heikkinen S, Lundbom N, Roine RO: Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. J Cereb Blood Flow Metab 24:1393–1399, 2004.
Kissela BM, Khoury J, Kleindorfer D, Woo D, Schneider A, Alwell K, Miller R, Ewing I, Moomaw CJ, Szaflarski JP, Gebel J, Shukla R, Broderick JP: Epidemiology of ischemic stroke in patients with diabetes: the Greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 2005.28:355–359.
Centers for Disease Control and Prevention: National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2002. Atlanta, GA, Department of Health and Human Services, Centers for Disease Control and Prevention Atlanta, 2003.
Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener HC: Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 32:2559–2566, 2001
Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, Woo D, Szaflarski J, Gebel J, Moomaw C, Pancioli A. Stroke in a biracial population the excess burden of stroke among blacks. Stroke. 2004 Feb 1;35(2):426-31.
Ottenbacher KJ, Ostir GV, Peek MK, Markides KS. Diabetes mellitus as a risk factor for stroke incidence and mortality in Mexican American older adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2004 Jun 1;59(6):M640-5.
Karapanayiotides TH, Piechowski-Jozwiak B, Van Melle G, Bogousslavsky J, Devuyst G. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology. 2004 May 11;62(9):1558-62.
Saad MI, Abdelkhalek TM, Saleh MM, Kamel MA, Youssef M, Tawfik SH, et al. Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells. Endocrine. 2015; 50:537–567.
Shou J, Zhou L, Zhu S, Zhang X. Diabetes is an Independent Risk Factor for Stroke Recurrence in Stroke Patients: A Meta-analysis. J Stroke Cerebrovasc Dis. 2015; 24(9):1961–1968.
Jia Q, Zhao X, Wang C, Wang Y, Yan Y, Li H, et al. Diabetes and poor outcomes within 6 months after acute ischemic stroke: the China National Stroke Registry. Stroke. 2011; 42(10):2758–2762.
Diener HC, Ringleb PA, Savi P. Clopidogrel for the secondary prevention of stroke. Expert Opin Pharmacother. 2005; 6(5):755–764.
Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283–292. .
Merwick A, Albers GW, Amarenco P, Arsava EM, Ay H, Calvet D, et al. Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol. 2010; 9(11):1060–1069.
Nezu T, Yokota C, Uehara T, et al. Preserved acetazolamide reactivity in lacunar patients with severe white-matter lesions: 15O-labeled gas and H2O positron emission tomography studies. Journal of Cerebral Blood Flow & Metabolism. 2012;32:844–850.
Aso K, Ogasawara K, Sasaki M, et al. Preoperative cerebrovascular reactivity to acetazolamide measured by brain perfusion SPECT predicts development of cerebral ischemic lesions caused by microemboli during carotid endarterectomy. European Journal of Nuclear Medicine and Molecular Imaging. 2009;36(2):294–301.
Willie CK, Colino FL, Bailey DM, et al. Utility of transcranial Doppler ultrasound for the integrative assessment of cerebrovascular function. Journal of Neuroscience Methods. 2011;196(2):221–237
Schwertfeger N, Neu P, Schlattmann P, Lemke H, Heuser I, Bajbouj M. Cerebrovascular reactivity over time course in healthy subjects. Journal of the Neurological Sciences. 2006;249(2):135–139.
Markus H, Cullinane M. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain. 2001;124(3):457–467.
Yeo LL, Sharma VK. Role of transcranial doppler ultrasonography in cerebrovascular disease. Recent Patents on CNS Drug Discovery. 2010;5(1):1–13.
Adams RJ. TCD in sickle cell disease: an important and useful test. Pediatric Radiology. 2005;35(3):229–234.
Rigamonti A, Ackery A, Baker AJ. Transcranial Doppler monitoring in subarachnoid hemorrhage: a critical tool in critical care. Canadian Journal of Anesthesia. 2008;55(2):112–123.
Arenillas JF, Molina CA, Montaner J, Abilleira S, González-Sánchez MA, Álvarez-Sabín J. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke. 2001;32(12):2898–2904. Christou I, Felberg RA, Demchuk AM, et al. A broad diagnostic battery for bedside transcranial Doppler to detect flow changes with internal carotid artery stenosis or occlusion. Journal of Neuroimaging.2001;11(3):236–242.
Moreno JA, Mesalles E, Gener J, et al. Evaluating the outcome of severe head injury with transcranial Doppler ultrasonography. Neurosurgical Focus. 2000;8(1):1–7.
Pennekamp CWA, Moll FL, de Borst GJ. The potential benefits and the role of cerebral monitoring in carotid endarterectomy. Current Opinion in Anaesthesiology. 2011;24(6):693–697.
World health organization .Appropriate body mass index for asian population and its implications for policy and intervention stratigies.The lancet.2004:157-163. Bray GA.Obesity in Nutrition .Harrison’s principles of internal medicine.17th edit.McGrew-Hills.2008.
Garabed E.The average man and indeces of obesity .Nephrol.Dial.Transplant.2008;23(1):47-51.
Palazzo, Paola, et al. "Cerebral hemodynamics and systemic endothelial function are already impaired in well-controlled type 2 diabetic patients, with short-term disease." PloS one 8.12 (2013): e83287.
Di Flaviani A, Picconi F, Di Stefano P, Giordani I, Malandrucco I, et al. (2011) Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients.Diabetes Care 34: 1605–9 .
Last D, Alsop DC, Abduljalil AM, Marquis RP, De Bazelaire C, Hu K, Cavallerano J, Novak V. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes care. 2007 May 1;30(5):1193-9.
Yamamoto M, Meyer JS, Sakai F, Yamaguchi F. Aging and cerebral vasodilator responses to hypercarbia. Arch Neurol. 1980; 37: 489–496.
Vuletić, V., Čengić, L., Bašić, S., Sporiš, D., Rahelić, D. and Demarin, V., 2011. Impaired cerebral vasoreactivity in type 2 diabetes mellitus. Collegium antropologicum, 35(1), pp.27-31.
Selim M, Jones R, Novak P, Zhao P, Novak V. The effects of body mass index on cerebral blood flow velocity. Clinical Autonomic Research. 2008 Dec 1;18(6):331-8.
Kadoi, Y., Hinohara, H., Kunimoto, F., Saito, S., Ide, M., Hiraoka, H., Kawahara, F. and Goto, F., 2003. Diabetic patients have an impaired cerebral vasodilatory response to hypercapnia under propofol anesthesia. Stroke, 34(10), pp.2399-2403
